Malaysia Cold Pain Therapy Market Report 2022 to 2030

Malaysia Cold Pain Therapy Market Analysis

$ 3999

The Malaysia Cold Pain Therapy Market was valued at $4 Mn in 2022 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $5 Mn by 2030. The key drivers of this industry include the rising burden of chronic pain disorders, growing consumer preference for non-invasive techniques, and expanded product offerings in the therapeutics industry. The industry is primarily dominated by players such as Duopharma, Phamaniaga, Ossur, Rohto, Pfizer, Hisamitsu, and Johnson & Johnson among others.

CATEGORY: Pharmaceuticals GEOGRAPHY: Malaysia AUTHOR: Riddhi Solanki

Buy Now

Malaysia Cold Pain Therapy Market Analysis Executive Summary

The Malaysia Cold Pain Therapy Market is at around $4 Mn in 2022 and is projected to reach $5 Mn in 2030, exhibiting a CAGR of 5.4% during the forecast period.

Cryotherapy, known as cold pain therapy, is the use of freezing temperatures to reduce pain and inflammation, used to treat acute injuries, post-surgical discomfort, and several musculoskeletal diseases. It works by constricting blood vessels and decreasing metabolic activity, which reduces swelling and numbness in the affected area using applications such as ice packs, cold compresses, ice baths, and specialized devices that provide controlled cold temperatures to specific body areas. Several companies providing cold pain therapy products, include Ossur, Biofreeze, DonJoy, and Chattanooga.

Malaysia has an estimated prevalence of 7% for chronic pain diseases. The market is driven by factors such as the increasing burden of chronic pain diseases, growing consumer preference for non-invasive techniques, and expanded product offerings. However, factors like competition from pharmaceutical alternatives, affordability challenges, and regulatory hurdles limit the market's growth and potential.

Market Dynamics

Market Growth Drivers

Increasing burden of pain disorders: Malaysia's aging population is propelling the demand for pain management. As people get older, they are more likely to develop chronic pain disorders such as arthritis, musculoskeletal disorders, and joint pain which affects around 7% of the population. This is further contributed by the rising prevalence of sedentary lifestyles and obesity driving demand and market growth

Preference for non-invasive treatments: Concerns about the potential adverse effects of prescription drugs are driving consumer preference for non-invasive pain management treatments. Cryotherapy offers a convenient and effective alternative improving its adoption by consumers.

Expanding product offerings: New product offerings in this market include differentiators such as flexible temperatures, extended freezing effects, and customized application designs. This product diversification seeks to meet a variety of pain areas and preferences, thereby appealing to a wider range of consumers. Furthermore, the growing prominence of online platforms for purchasing cold therapy products improves accessibility and convenience for consumers.

Market Restraints

Affordability challenges: Many cryotherapy products, particularly advanced devices such as cryo chambers and prescription alternatives, may be more expensive than over-the-counter (OTC) drugs. Insufficient insurance coverage for these products could discourage consumers, especially those with financial limitations. Elevated import costs for certain brands or technologies may result in increased consumer prices, exacerbating affordability challenges.

Competition from pharmaceutical alternatives: The market competes with alternative pain management choices such as pain medications, physiotherapy, and acupuncture. Consumer preferences, perceived efficacy, and cost-effectiveness lead patients to select different treatment options. To attract and retain consumers, it is necessary to properly communicate and demonstrate the effectiveness of cold pain therapy in comparison to other options.

Regulatory challenges: Stringent regulatory procedures for the approval of new cold pain therapy products may prolong market entry and restrict product variety. Complicated approval processes and the associated expenses may dissuade smaller enterprises from participating in the market, impacting both competition and innovation. Market expansion can also be hindered by restricted access to certain brands or technologies, arising from regulatory constraints or challenges in distribution.

Healthcare Policies and Regulatory Landscape

In Malaysia, the main regulatory body overseeing the approval and licensure of drugs and pharmaceuticals is the National Pharmaceutical Regulatory Agency (NPRA), which operates under the Ministry of Health (MOH). The NPRA is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products in the country. The agency conducts thorough evaluations of applications for drug registration, monitors post-marketing activities, and collaborates with international regulatory bodies to align with global standards.

The process of obtaining licensure for drugs in Malaysia involves several key steps. The NPRA reviews these submissions and conducts inspections of manufacturing facilities to ensure compliance with Good Manufacturing Practice (GMP) standards. The agency evaluates the risk-benefit profile of the drug before granting marketing authorization.

New entrants into the pharmaceutical market must navigate this regulatory environment by adhering to the established guidelines and demonstrating the quality and safety of their products. Understanding and compliance with the regulatory requirements are crucial for success in entering the Malaysian pharmaceutical market.

Competitive Landscape

Key Players

Hisamitsu Pharmaceutical
Johnson & Johnson
Duopharma
Beiersdorf
DJO Global Inc
Rohto Pharmaceutical
Ossur
Pfizer
Pharmaniaga
Cardinal Health

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Malaysia Cold Pain Therapy Market Segmentation

By Therapy Type

Icepack
Chamber
Cryosurgery

By Product Type

OTC Products
Prescription Drugs

By Application

Dermatology
Oncology
Musculoskeletal disorders
Pain management
Sports medicine
Ophthalmology
Others

By End Users

Hospitals and clinics
Sports person
Adults
Others

By Distribution channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.